Rye KA - Search Results

1

Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.

Ong KL, Januszewski AS, O'Connell R, Buizen L, Jenkins AJ, Xu A, Sullivan DR, Barter PJ, Scott RS, Taskinen MR, Rye KA, Keech AC; FIELD study investigators. Ong KL, et al. Among authors: rye ka. Diabetologia. 2015 Sep;58(9):2035-44. doi: 10.1007/s00125-015-3652-2. Epub 2015 Jun 9. Diabetologia. 2015. PMID: 26055067 Clinical Trial.

2

Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells.

Barter PJ, Baker PW, Rye KA. Barter PJ, et al. Among authors: rye ka. Curr Opin Lipidol. 2002 Jun;13(3):285-8. doi: 10.1097/00041433-200206000-00008. Curr Opin Lipidol. 2002. PMID: 12045398 Review.

3

Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.

Rye KA, Duong M, Psaltis MK, Curtiss LK, Bonnet DJ, Stocker R, Barter PJ. Rye KA, et al. Biochemistry. 2002 Oct 15;41(41):12538-45. doi: 10.1021/bi025998k. Biochemistry. 2002. PMID: 12369845

4

Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits.

Kee P, Rye KA, Taylor JL, Barrett PH, Barter PJ. Kee P, et al. Among authors: rye ka. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1912-7. doi: 10.1161/01.atv.0000038485.94020.7f. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426224

5

Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.

Rye KA, Wee K, Curtiss LK, Bonnet DJ, Barter PJ. Rye KA, et al. J Biol Chem. 2003 Jun 20;278(25):22530-6. doi: 10.1074/jbc.M213250200. Epub 2003 Apr 10. J Biol Chem. 2003. PMID: 12690114 Free article.

6

Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.

Rye KA, Barter PJ. Rye KA, et al. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):421-8. doi: 10.1161/01.ATV.0000104029.74961.f5. Epub 2003 Oct 30. Arterioscler Thromb Vasc Biol. 2004. PMID: 14592845 Review.

7

Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.

Duong M, Psaltis M, Rader DJ, Marchadier D, Barter PJ, Rye KA. Duong M, et al. Among authors: rye ka. Biochemistry. 2003 Nov 25;42(46):13778-85. doi: 10.1021/bi034990n. Biochemistry. 2003. PMID: 14622025

8

Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.

Kockx M, Rye KA, Gaus K, Quinn CM, Wright J, Sloane T, Sviridov D, Fu Y, Sullivan D, Burnett JR, Rust S, Assmann G, Anantharamaiah GM, Palgunachari MN, Katz SL, Phillips MC, Dean RT, Jessup W, Kritharides L. Kockx M, et al. Among authors: rye ka. J Biol Chem. 2004 Jun 18;279(25):25966-77. doi: 10.1074/jbc.M401177200. Epub 2004 Apr 1. J Biol Chem. 2004. PMID: 15066991 Free article.

9

High-density lipoproteins neutralize C-reactive protein proinflammatory activity.

Wadham C, Albanese N, Roberts J, Wang L, Bagley CJ, Gamble JR, Rye KA, Barter PJ, Vadas MA, Xia P. Wadham C, et al. Among authors: rye ka. Circulation. 2004 May 4;109(17):2116-22. doi: 10.1161/01.CIR.0000127419.45975.26. Epub 2004 Apr 12. Circulation. 2004. PMID: 15078800

10

Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner.

Hime NJ, Drew KJ, Hahn C, Barter PJ, Rye KA. Hime NJ, et al. Among authors: rye ka. Biochemistry. 2004 Sep 28;43(38):12306-14. doi: 10.1021/bi036305i. Biochemistry. 2004. PMID: 15379569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page